Even as researchers look for biomarkers to forecast ketamine reaction, clinicians locate on their own with a conundrum: Which patients should really start with IV ketamine, and which with Spravato? And just how do the two compare head to head in genuine response to treatment? This rise in mTOR signaling https://hansr111tiw9.scrappingwiki.com/user